E25Bio Inc.
Brookline, MA · Founded 2018 · CIK 0001786210 · Medtech · Defunct
Multiplexed point-of-care diagnostic tests (SimPlex and 3Plex) for simultaneous detection of dengue, Zika, and chikungunya viral antigens in whole blood, paired with a mobile smartphone application fo
e25bio.com →- Grants
- $3.6M
- 5 awards
- Sector median: 1
- Raised
- $6.8M
- 4 Form D · Jun 2021
- 64 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 6
- 0 granted · 6 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2019202020212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Integrated point-of-care diagnostic and data reporting platform for emerging arboviruses | $150,781 | |
| Federal grant | Department of Health and Human Services · Phase I · Integrated point-of-care diagnostic and data reporting platform for emerging arboviruses | $150,781 | |
| Private capital raised | Form D · SEC | $2,299,970 | |
| Private capital raised | Form D · SEC | $2,000,000 | |
| Private capital raised | Form D · SEC | $2,000,000 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · Integrated point-of-care diagnostic and data reporting platform for emerging arboviruses | $799,930 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase II · Integrated point-of-care diagnostic and data reporting platform for emerging arboviruses | $1,626,940 | |
| Private capital raised | Form D · SEC | $500,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Integrated point-of-care diagnostic and data reporting platform for emerging arboviruses | $827,010 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1758 | ELIZUR CORPORATION | — | — |
| 1759 | AMG DETECTION, INC. | — | — |
| 1760 | EVOLUTION DEVICES, INC. | — | — |
| 1761 | E25Bio Inc. | — | $6.8M |
| 1762 | LUMITHERA INC | — | $6.7M |
| 1763 | Bruin Biometrics, LLC | — | — |
| 1764 | WICKED SHEETS, LLC | — | $1.4M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Irene BoschDirector · Executive Officer
- Prashant ChoutaDirector · Executive Officer
- Ann DeWittDirector
- Shadah EnriqueExecutive Officer
- Bobby HerraraExecutive Officer
- Bobby HerreraExecutive Officer
- Jeff TakleDirector · Executive Officer
Patents
- High Throughput Screening For Monoclonal Antibody Pairsapplication
- Rapid Diagnostic Immunoassay For Presence Of Antibodiesapplication
- Rapid Diagnostic Immunoassay For Presence Of Viral Antigenapplication
- High Throughput Screening For Monoclonal Antibody Pairsapplication
- Rapid Diagnostic Immunoassay For Presence Of Antibodiesapplication
- Rapid Diagnostic Immunoassay For Presence Of Viral Antigenapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.